Skip to content

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence, Efficacy and Durability Trial

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04881721
Enrollment
15
Registered
2021-05-11
Start date
2021-08-25
Completion date
2023-12-31
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Brief summary

In this proposed study, the investigators aim to evaluate a modified suture urethropexy technique for the treatment of female stress urinary incontinence. Participants will be followed with postoperative visits after 2 weeks, 2 months, and 12 months. Pelvic floor ultrasound imaging will be performed before surgery and after 2 months and 12 months, to evaluate urethral mobility.

Detailed description

This study is designed as a prospective observational study. The hypothesis is that suture urethropexy will improve stress urinary incontinence symptoms in participants with stress urinary incontinence and normal urethral closure pressure at 2 months and 12 months after surgery. Specific Aims: Aim 1: Investigate the efficacy of this mesh-free suture based surgical technique for improving SUI symptoms Aim 2: Investigate the efficacy of this mesh-free suture based surgical technique on key urethral support defects observed with 3D ultrasound

Interventions

PROCEDUREUrethropexy

Suture based (Mesh-free) surgery to stabilize the urethra for the treatment of stress urinary incontinence

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older with stress dominant urinary incontinence * Stress urinary incontinence confirmed by testing (e.g. urodynamics) * Able to provide informed consent and attend post-operative visits

Exclusion criteria

* Detrusor overactivity (\> 40cm H2O) * Maximum Urethral Closure Pressure (\< 40 cm H2O) * Post void residual \> 150 mL * Prior surgery for stress urinary incontinence with retained material (e.g. bulking agent, sling)

Design outcomes

Primary

MeasureTime frameDescription
Stress urinary incontinence symptoms2 weeksSeverity of stress urinary incontinence symptoms by questionnaire
Voiding dysfunctionWithin 1 year of surgeryRate of urinary retention after surgery

Secondary

MeasureTime frameDescription
Distal Urethral Motion2 monthsDistal urethral swing angle during Valsalva measured via pelvic ultrasound
Proximal Urethral Motion2 monthsProximal urethral swing angle during Valsalva measured via pelvic ultrasound
Post-operative complicationsWithin 1 year of surgeryRate of post-operative complications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026